AGP Executive Report
Last update: 7 hours agoCancer Care Update: Results from the phase 3 ROSELLA trial report that relacorilant (Lifyorli) added to nab-paclitaxel improved overall survival for platinum-resistant ovarian cancer, with benefit seen across prior taxane exposure histories. Puerto Rico Health Workforce: Puerto Rico’s Economic Development Bank and the Department of Health convened a roundtable on retaining healthcare professionals, focusing on financing, hospital infrastructure, telemedicine, credentialing, training, and incentives to slow the outflow of specialists. Healthy Aging Push: Puerto Rico reaffirmed its 10-year Healthy Aging Plan with PAHO support, highlighting long-term care expansion, person-centered services, and stronger support for informal caregivers as the island’s older-adult population grows. Local Health Policy Spotlight: The Puerto Rico Health & Insurance Conference opened with warnings about “Medicaid cliffs” and the heavy chronic-disease burden, noting the system’s reliance on federal funding and structural constraints. Pet Travel & Vet Records: PadsPass CEO Lauren Anders Brown is set to speak at Caribbean Week NYC on digital tools that help pet owners store health records and verify travel compliance through connected veterinary clinics. Public Health/Prevention: Puerto Rico’s Agriculture Department launched a preventive distribution of tissue-cultured, disease-resistant plantain and banana seedlings to protect farmers against Fusarium threats.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Ratio Therapeutics And Pharmalogic Expand Manufacturing Collaboration To Support Clinical Development Of [Ac-225]RTX-2358](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/17963019-648340549-logo-100x25.jpeg){kind=logo}
